A Anthranilic acid, N-(2,3-xylyl)- CEP of the European Pharmacopoeia monograph is often referred to as a Anthranilic acid, N-(2,3-xylyl)- Certificate of Suitability (COS). The purpose of a Anthranilic acid, N-(2,3-xylyl)- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Anthranilic acid, N-(2,3-xylyl)- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Anthranilic acid, N-(2,3-xylyl)- to their clients by showing that a Anthranilic acid, N-(2,3-xylyl)- CEP has been issued for it. The manufacturer submits a Anthranilic acid, N-(2,3-xylyl)- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Anthranilic acid, N-(2,3-xylyl)- CEP holder for the record. Additionally, the data presented in the Anthranilic acid, N-(2,3-xylyl)- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Anthranilic acid, N-(2,3-xylyl)- DMF.
A Anthranilic acid, N-(2,3-xylyl)- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Anthranilic acid, N-(2,3-xylyl)- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Anthranilic acid, N-(2,3-xylyl)- suppliers with CEP (COS) on PharmaCompass.